GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
POU4F2 | hg19_v2_chr4_+_147560042_147560046 | 0.04 | 5.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr18_+_74240610 Show fit | 9.97 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
long intergenic non-protein coding RNA 908 |
|
chr3_-_58613323 Show fit | 9.75 |
ENST00000474531.1
ENST00000465970.1 |
family with sequence similarity 107, member A |
|
chr5_-_134914673 Show fit | 8.05 |
ENST00000512158.1
|
chemokine (C-X-C motif) ligand 14 |
|
chr6_+_151042224 Show fit | 6.95 |
ENST00000358517.2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
|
chr10_-_73848086 Show fit | 5.09 |
ENST00000536168.1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
|
chr17_-_9929581 Show fit | 4.45 |
ENST00000437099.2
ENST00000396115.2 |
growth arrest-specific 7 |
|
chr8_-_18541603 Show fit | 4.05 |
ENST00000428502.2
|
pleckstrin and Sec7 domain containing 3 |
|
chr6_+_39760129 Show fit | 3.88 |
ENST00000274867.4
|
dishevelled associated activator of morphogenesis 2 |
|
chr5_-_140998481 Show fit | 3.87 |
ENST00000518047.1
|
diaphanous-related formin 1 |
|
chr3_+_115342349 Show fit | 3.76 |
ENST00000393780.3
|
growth associated protein 43 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.0 | GO:0001558 | regulation of cell growth(GO:0001558) |
0.4 | 8.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.2 | 8.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 6.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.5 | 6.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 4.6 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.2 | 4.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 3.9 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.4 | 3.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 3.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 8.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 6.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.5 | 3.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 3.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 3.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 3.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 2.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 2.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 2.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 8.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 8.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 6.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 4.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 3.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 3.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 3.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 3.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 3.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 8.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 8.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 8.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 3.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 3.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 3.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 2.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.2 | 2.7 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 1.5 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 1.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |